Naproxen/Phosphatidylcholine

萘普生/磷脂酰胆碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNaproxen/Phosphatidylcholine
Drug Alias NamePhosphatidylcholine/Naproxen磷脂酰胆碱萘普生Naproxen and Phosphatidylcholine磷脂酰胆碱/萘普生Phosphatidylcholine and Naproxen +[6] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Naproxen
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPlx Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPlx PharmaPlx Pharma Inc
Active IndicationsN/A
Inactive IndicationsArthritis

Other Information

ATC CodeN/A
Related LinksN/A